A Curated Platform of Equity & Options Market Intelligence
Select Page

FOLD

Search by
TICKER SYMBOL

Amicus Therapeutics Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

11.73

-0.13

(-1.096%)

Volume:

1,210,745

52 week range:

9.7 - 14.57

Market Cap:

3.465B

Company Description:

amicus therapeutics is a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. we have a unique set of platform technologies and medicines in development for patients living with the lysosomal storage disorders fabry disease and pompe disease and we are committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for these and other rare diseases. the needs of patients in the rare disease community are at the center of our inventive science, our commercial organization, and our clinical programs. our goal throughout all levels of the organization is to make a meaningful difference in the lives of these patients and their caregivers. several opportunities are available to join our team as we build a leading global biotechnology company focused on rare metabolic diseases. our amicus footprint spans 27 countries including our g